Mary Munson

@marymunson4.bsky.social

Multidisciplinary research at UMass Chan focused on membrane trafficking. Striving to make academic science a more diverse, equitable, welcoming and inclusive place. President of the American Society for Cell Biology (ASCB). Opinions are mine (she/her)

Lots of stories across Pennsylvania about NIH grant terminations at Pitt and Penn. This is why speaking out matters. Even Congress critters who generally support the administration get pressured into actually supporting their constituents. www.wesanews.org/health-scien...

McCormick, Fetterman question termination of more than 100 health research grants

Pennsylvania’s senators are demanding information about more than 150 health research grants canceled by the U.S. Department of Health and Human Services this summer.

wesanews.org

📢 Postdoc position open in the Chioccioli Lab @YaleMed We study alveolar stem cell fate, injury and repair — live imaging of precision-cut lung slices, mouse genetics, single-cell genomics. Bioinformatics a plus. Closes 22 Sept. DM me or email for details. Please share! 🫁

NIH plans to block international researchers on visas from accessing key funding avenue: the K99/R00. Devastating news for the international research training community, who strongly contribute to US biomedical research. All will feel this great loss! www.statnews.com/2026/08/07/n...

NIH plans to block international researchers on visas from accessing key funding avenue

The NIH plans to close the door on one of the few pathways available to international students on visas to forge a career in biomedical research in the U.S.

statnews.com

"Pancreatic cancer mRNA vaccine shows lasting results in an early trial: Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later."

Pancreatic cancer mRNA vaccine shows lasting results in an early trial

Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.

nbcnews.com

This is truly one of the most remarkable advances in cancer therapy in history: metastatic pancreatic cancer was a short-term death sentence and this new approach put many of them into long term remission. This is why we invest in science, and why RFKs effort to kill this work is misguided 🧪

Ignacio Gallup-Diaz@igallupd.bsky.social · 5mo ago

"Pancreatic cancer mRNA vaccine shows lasting results in an early trial: Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later."

Happy to announce that my institution, @irbbarcelona.org, is opening two group leader positions, 1 in chemical biology and 1 in structural biology, to strengthen our expertise in molecular sciences: please spread the word !

IRB Barcelona@irbbarcelona.org · 7mo ago

We are #hiring! #GroupLeader positions open at #IRBBarcelona in #ChemicalBiology and #StructuralBiology. Application deadline: May 22, 2026 𝗚𝗿𝗼𝘂𝗽 𝗟𝗲𝗮𝗱𝗲𝗿 𝗶𝗻 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 ➡️ https://shorturl.at/1tE3n 𝗚𝗿𝗼𝘂𝗽 𝗟𝗲𝗮𝗱𝗲𝗿 𝗶𝗻 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 ➡️ https://shorturl.at/eKiJn #IRBJobs #Jobs #AcademicSky

BREAKING: @delauro.house.gov announces at a House Oversight hearing with NIH director Jay Bhattacharya that OMB approved the agency's apportionment last night. That means the agency should have access to its appropriated funds — 42 days after its spending bill passed.

Max Kozlov@maxkozlov.bsky.social · 7mo ago

Congress rejected massive cuts to US science budgets for 2026, but much of the money still isn’t flowing to researchers. The culprit? The White House Office of Management and Budget (OMB) is quietly slow-walking the release of funds. 🧵👇

Nature published another pile of trash i am trying to catch up on some of my reading but this one is getting under my skin so here’s a thread highlighting why this piece is either ill-informed or intentionally ignorant of a wealth of knowledge from embodied cog sci and related fields 1/



    COMMENT
    02 February 2026

Does AI already have human-level intelligence? The evidence is clear
The vision of human-level machine intelligence laid out by Alan Turing in the 1950s is now a reality. Eyes unclouded by dread or hype will help us to prepare for what comes next.

The data is in: the NIH goalposts have shifted. What were once almost certain fundable scores have become coin flips and what used to be likely grants have become aspirational, leading to fewer awards. Another manifestation of how HHS policies have led to fewer awards and less science.

Graph of award probability of R35 and R01 from NIH factbook as a function of review rank percentile. As is apparent, 2025 is a significant departure, with lower award probabilities at all scores <40 and significant departures from norm, where even being in the top 10% is no longer a nearly certain indicator of success.

Data source: https://report.nih.gov/nihdatabook/report/302

My weekly update on NIH funding This includes awards made through 2/27/26 Warning: This thread contains data compiled by a known deranged_activist™. Do not read while operating heavy machinery. 1/9

A photo of Doc Brown from Back to the Future holding jumper cables labelled "Deranged Activist" with a grant of NIH funding curves below it.

🧵 After years out of the field, I and my lab are again working on bacterial type IV pili. We have just posted our first preprints, and I'm excited to share what we have discovered. This shows Neisseria gonorrheae bacteria infecting a human epithelical cell. Here, you can see the pili in red. 1/

Fluorescence micrograph. Emma Miller and Alex Merz, unpublished.

I've heard this position articulated by a lot of people, but I think this is hard to make precise. Much of this tracks a problem we already know in science: standards of authorship are not stable and there are many difficult edge cases. Consider these cases...

Iris van Rooij 💭@irisvanrooij.bsky.social · 7mo ago

Seeing ppl debate how to deal with paper submissions that are partly written by “AI”. Why are we having that conversation? I would refuse to review or edit any paper that was not 100% written by its authors (i.e., the people who have authorial responsibility for the creation of a papers content).